Astria Therapeutics's market cap is currently $711.08M. The company's EPS TTM is $-0.57; its P/E ratio is -6.21; Astria Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
